Cargando…

Examining non-medical prescribing trends in New Zealand: 2016–2020

BACKGROUND: Population growth and general practitioner workforce constraints are creating increasing demand for health services in New Zealand (NZ) and internationally. Non-medical prescribing (NMP) is one strategy that has been introduced to help manage this. Little is known about the NMP practice...

Descripción completa

Detalles Bibliográficos
Autores principales: Raghunandan, Rakhee, Marra, Carlo A., Tordoff, June, Smith, Alesha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094524/
https://www.ncbi.nlm.nih.gov/pubmed/33941188
http://dx.doi.org/10.1186/s12913-021-06435-y
_version_ 1783687987034324992
author Raghunandan, Rakhee
Marra, Carlo A.
Tordoff, June
Smith, Alesha
author_facet Raghunandan, Rakhee
Marra, Carlo A.
Tordoff, June
Smith, Alesha
author_sort Raghunandan, Rakhee
collection PubMed
description BACKGROUND: Population growth and general practitioner workforce constraints are creating increasing demand for health services in New Zealand (NZ) and internationally. Non-medical prescribing (NMP) is one strategy that has been introduced to help manage this. Little is known about the NMP practice trends in NZ. The aim of this study was to provide a current overview of the scale, scope, and trends of NMP practice in NZ. METHODS: All claims for community dispensed medicines prescribed by a non-medical prescriber were extracted from the NZ Pharmaceutical Collection for the period 2016–2020. Patient demographics were retrieved from the Primary Health Organisation enrolment collection. These national databases contain prescription information for all subsidised community pharmacy medicines dispensed and healthcare enrolment data for 96% of New Zealanders. RESULTS: The proportion of prescriptions written by all NMP providers and patients receiving NMP prescriptions increased each year from 1.8% (2016) to 3.6% (2019) and 8.4% (2016) to 14.4% (2019) respectively. From 2016 to 2019, the proportion of NMP patients who had at least one NMP prescription increased from 26% to 39% for nurse prescribers, from 1% to 9% for pharmacist prescribers, from 2% to 3% for dietitian prescribers, and decreased from 47% to 22% for dentists, and from 20% to 12% for midwives. The most commonly prescribed medicines were antibiotics (amoxicillin, amoxicillin with clavulanic acid, and metronidazole), and analgesics (paracetamol, and codeine phosphate). While some NMP providers were prescribing for patients with greater health needs, all NMP providers could be better utilised to reach more of these patients. CONCLUSIONS: This study highlights that although the NMP service has been implemented in NZ, it has yet to become mainstream healthcare practice. This work provides a baseline to evaluate the NMP service moving forward and enable policy development. Improved implementation and integration of primary care NMP services can ensure continued access to prescribing services and medicines for our communities.
format Online
Article
Text
id pubmed-8094524
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80945242021-05-04 Examining non-medical prescribing trends in New Zealand: 2016–2020 Raghunandan, Rakhee Marra, Carlo A. Tordoff, June Smith, Alesha BMC Health Serv Res Research Article BACKGROUND: Population growth and general practitioner workforce constraints are creating increasing demand for health services in New Zealand (NZ) and internationally. Non-medical prescribing (NMP) is one strategy that has been introduced to help manage this. Little is known about the NMP practice trends in NZ. The aim of this study was to provide a current overview of the scale, scope, and trends of NMP practice in NZ. METHODS: All claims for community dispensed medicines prescribed by a non-medical prescriber were extracted from the NZ Pharmaceutical Collection for the period 2016–2020. Patient demographics were retrieved from the Primary Health Organisation enrolment collection. These national databases contain prescription information for all subsidised community pharmacy medicines dispensed and healthcare enrolment data for 96% of New Zealanders. RESULTS: The proportion of prescriptions written by all NMP providers and patients receiving NMP prescriptions increased each year from 1.8% (2016) to 3.6% (2019) and 8.4% (2016) to 14.4% (2019) respectively. From 2016 to 2019, the proportion of NMP patients who had at least one NMP prescription increased from 26% to 39% for nurse prescribers, from 1% to 9% for pharmacist prescribers, from 2% to 3% for dietitian prescribers, and decreased from 47% to 22% for dentists, and from 20% to 12% for midwives. The most commonly prescribed medicines were antibiotics (amoxicillin, amoxicillin with clavulanic acid, and metronidazole), and analgesics (paracetamol, and codeine phosphate). While some NMP providers were prescribing for patients with greater health needs, all NMP providers could be better utilised to reach more of these patients. CONCLUSIONS: This study highlights that although the NMP service has been implemented in NZ, it has yet to become mainstream healthcare practice. This work provides a baseline to evaluate the NMP service moving forward and enable policy development. Improved implementation and integration of primary care NMP services can ensure continued access to prescribing services and medicines for our communities. BioMed Central 2021-05-03 /pmc/articles/PMC8094524/ /pubmed/33941188 http://dx.doi.org/10.1186/s12913-021-06435-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Raghunandan, Rakhee
Marra, Carlo A.
Tordoff, June
Smith, Alesha
Examining non-medical prescribing trends in New Zealand: 2016–2020
title Examining non-medical prescribing trends in New Zealand: 2016–2020
title_full Examining non-medical prescribing trends in New Zealand: 2016–2020
title_fullStr Examining non-medical prescribing trends in New Zealand: 2016–2020
title_full_unstemmed Examining non-medical prescribing trends in New Zealand: 2016–2020
title_short Examining non-medical prescribing trends in New Zealand: 2016–2020
title_sort examining non-medical prescribing trends in new zealand: 2016–2020
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094524/
https://www.ncbi.nlm.nih.gov/pubmed/33941188
http://dx.doi.org/10.1186/s12913-021-06435-y
work_keys_str_mv AT raghunandanrakhee examiningnonmedicalprescribingtrendsinnewzealand20162020
AT marracarloa examiningnonmedicalprescribingtrendsinnewzealand20162020
AT tordoffjune examiningnonmedicalprescribingtrendsinnewzealand20162020
AT smithalesha examiningnonmedicalprescribingtrendsinnewzealand20162020